Use and attitudes toward complementary and alternative medicine among university students: The role of gender and race

Salihu, Ejura Yetunde; Wallace, Lora Ebert

doi:10.1080/07448481.2022.2115296

Cited by 3 publications

(3 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Women exhibit a greater inclination towards complementary and alternative medicine compared to men, as shown by numerous studies across a variety of diseases 21–25 . This trend appears to transcend borders and is observed in many countries worldwide, including the United States, 21,22 Malaysia, 23 Finland, 24 and Italy 26 …”

Section: Discussionmentioning

confidence: 97%

“…In regard to children's participation in research on complementary medicine, our findings indicate that female parents, in comparison to males and older parents, were more likely to express agreement. Women exhibit a greater inclination towards complementary and alternative medicine compared to men, as shown by numerous studies across a variety of diseases 21–25 . This trend appears to transcend borders and is observed in many countries worldwide, including the United States, 21,22 Malaysia, 23 Finland, 24 and Italy 26 …”

Section: Discussionmentioning

confidence: 97%

“…Women exhibit a greater inclination towards complementary and alternative medicine compared to men, as shown by numerous studies across a variety of diseases. [21][22][23][24][25] This trend appears to transcend borders and is observed in many countries worldwide, including the United States, 21,22 Malaysia, 23 Finland, 24 and Italy. 26 Our study revealed a noteworthy correlation between patients designating their gastroenterologist as their primary source of knowledge about IBD and its treatment, and a heightened willingness to participate in genetics and nutrition studies.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Parental perspectives on pediatric inflammatory bowel disease: Unraveling concerns, and study participation willingness

Eindor‐Abarbanel,

Pinchevski,

Shalem

et al. 2024

J. pediatr. gastroenterol. nutr.

View full text Add to dashboard Cite

ObjectivesThe impact of disease burden extends beyond pediatric inflammatory bowel disease (IBD) patients to include their parents. Previous studies, predating the biologic era, have highlighted parental concerns about potential side effects associated with IBD medications. However, there is a notable gap in the literature regarding parents' perceptions of clinical studies involving pediatric IBD patients. This study aims to explore the specific concerns troubling parents of children with IBD, identifying factors influencing these concerns, and assesses parental willingness to allow their child's participation in clinical studies.MethodsUtilizing social media, we disseminated an anonymous questionnaire to parents of pediatric IBD patients. The questionnaire encompassed queries about parental willingness for their child to partake in clinical studies, aspects of the disease deemed bothersome, and the sense of coherence scale (SOC).ResultsResponses were obtained from 101 parents, with a mean age of 46.4, of whom 82.2% were female. Concerns about potential future side effects of their child's medications surpassed worries about disease symptoms (80.04% vs. 73.47%). Linear regression analysis revealed that parents with lower SOC scores, limited medical care accessibility, and a higher age of the child at diagnosis, exhibited heightened concerns about the future impact of the disease on their child (p = 0.016, 0.003, and 0.045, respectively). While a majority rejected participation in studies involving new medications (54.5%), there was greater agreement for studies on nutritional therapies (84.2%) and complementary medicine (91.1%). Classification tree analysis indicated that women were more inclined to permit their child's participation in studies focusing on complementary medicine (adjusted p = 0.002).ConclusionParents of IBD patients express greater apprehension about potential side effects from IBD medications and display reluctance toward their child participating in clinical studies related to medications.

show abstract